REMYND
Their Contract Research Organization (CRO) helps their clients assess the effects of their experimental Alzheimer treatments in their proprietary mouse models. They serve the majority of the Top 10 pharmaco’s worldwide with clients in the US, Europe and Japan. They have provided pivotal in-vivo proof-of-concept data for several candidate drugs currently in clinical development, and work actively together with Dr. Sugimoto, the inventor of Aricept.
REMYND
Industry:
Biotechnology
Founded:
2012-01-01
Address:
Leuven, Vlaams-Brabant, Belgium
Country:
Belgium
Website Url:
http://www.remynd.com
Total Employee:
51+
Status:
Active
Contact:
+32 16 75 14 20
Email Addresses:
[email protected]
Total Funding:
24 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Content Delivery Network Google Universal Analytics Font Awesome Apache Amazon
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Current Advisors List
Current Employees Featured
Founder
Investors List
PMV
PMV investment in Series B - reMYND
FPIM
FPIM investment in Series B - reMYND
University of Leuven
University of Leuven investment in Series B - reMYND
Korys
Korys investment in Series B - reMYND
BNP Paribas Fortis
BNP Paribas Fortis investment in Series B - reMYND
Gemma Frisius Fund
Gemma Frisius Fund investment in Series B - reMYND
Korys
Korys investment in Series B - reMYND
University of Leuven
University of Leuven investment in Series B - reMYND
BNP Paribas Fortis
BNP Paribas Fortis investment in Series B - reMYND
PMV
PMV investment in Series B - reMYND
Official Site Inspections
http://www.remynd.com Semrush global rank: 5.77 M Semrush visits lastest month: 1.45 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
